These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
438 related items for PubMed ID: 32192508
1. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer. Xu H, Mao HL, Zhao XR, Li Y, Liu PS. J Ovarian Res; 2020 Mar 19; 13(1):31. PubMed ID: 32192508 [Abstract] [Full Text] [Related]
2. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A. Feng S, Luo S, Ji C, Shi J. World J Surg Oncol; 2020 Dec 01; 18(1):315. PubMed ID: 33261630 [Abstract] [Full Text] [Related]
3. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT. Xu H, Zheng JF, Hou CZ, Li Y, Liu PS. Cell Signal; 2019 Oct 01; 62():109341. PubMed ID: 31176022 [Abstract] [Full Text] [Related]
4. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A. Wang J, Liu L. J Ovarian Res; 2021 Nov 19; 14(1):165. PubMed ID: 34798882 [Abstract] [Full Text] [Related]
5. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis. Yang X, Xin N, Qu HJ, Wei L, Han Z. Anat Rec (Hoboken); 2020 Dec 19; 303(12):3024-3034. PubMed ID: 31930662 [Abstract] [Full Text] [Related]
6. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Zheng J, Zhou Y, Li XJ, Hu JM. Eur Rev Med Pharmacol Sci; 2019 Aug 19; 23(16):6839-6848. PubMed ID: 31486483 [Abstract] [Full Text] [Related]
7. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition. Xiong T, Wang Y, Zhang Y, Yuan J, Zhu C, Jiang W. Chin Med J (Engl); 2023 May 05; 136(9):1098-1110. PubMed ID: 36939239 [Abstract] [Full Text] [Related]
8. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Li QH, Liu Y, Chen S, Zong ZH, Du YP, Sheng XJ, Zhao Y. Biomed Pharmacother; 2019 Jun 05; 114():108832. PubMed ID: 30965236 [Abstract] [Full Text] [Related]
9. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis. Liu QY, Jiang XX, Tian HN, Guo HL, Guo H, Guo Y. Eur Rev Med Pharmacol Sci; 2020 Jul 05; 24(13):7266-7275. PubMed ID: 32706064 [Abstract] [Full Text] [Related]
10. CircRNA FGFR3 induces epithelial-mesenchymal transition of ovarian cancer by regulating miR-29a-3p/E2F1 axis. Zhou J, Dong ZN, Qiu BQ, Hu M, Liang XQ, Dai X, Hong D, Sun YF. Aging (Albany NY); 2020 Jul 15; 12(14):14080-14091. PubMed ID: 32668414 [Abstract] [Full Text] [Related]
11. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis. Wang K, Luo Q, Zhang Y, Xie X, Cheng W, Yao Q, Chen Y, Ren H, Li J, Pan Z. Aging (Albany NY); 2022 Dec 02; 15(8):2877-2890. PubMed ID: 36462499 [Abstract] [Full Text] [Related]
12. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR. Wang L, Yu M, Zhao S. J Cell Biochem; 2019 Oct 02; 120(10):17709-17722. PubMed ID: 31161607 [Abstract] [Full Text] [Related]
13. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p. Xu C, Zhu LX, Sun DM, Yao H, Han DX. Eur Rev Med Pharmacol Sci; 2020 Feb 02; 24(4):1672-1681. PubMed ID: 32141533 [Abstract] [Full Text] [Related]
14. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p. Wang L, Ren C, Xu Y, Yang L, Chen Y, Zhu Y. J Ovarian Res; 2021 Jun 11; 14(1):77. PubMed ID: 34116704 [Abstract] [Full Text] [Related]
15. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer. Zhou S, Xu A, Song T, Gao F, Sun H, Kong X. Cancer Biother Radiopharm; 2020 Nov 11; 35(9):650-660. PubMed ID: 32186927 [Abstract] [Full Text] [Related]
16. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T, Huang S, Han F. Cell Biochem Funct; 2020 Dec 11; 38(8):1089-1099. PubMed ID: 32638404 [Abstract] [Full Text] [Related]
17. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J, Tan S, Song L, Song L, Wang Y. Biomed Pharmacother; 2020 Jan 11; 121():109620. PubMed ID: 31810117 [Abstract] [Full Text] [Related]
18. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene. Li Y, Zhou J, Wang J, Chen X, Zhu Y, Chen Y. Biol Res; 2020 Mar 10; 53(1):10. PubMed ID: 32156314 [Abstract] [Full Text] [Related]
19. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H, Li H, Silva MA, Guan Y, Yang L, Zhu L, Zhang Z, Li G, Ren C. J Exp Clin Cancer Res; 2019 Aug 14; 38(1):356. PubMed ID: 31412903 [Abstract] [Full Text] [Related]
20. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C. Cell Physiol Biochem; 2018 Aug 14; 50(3):987-1004. PubMed ID: 30355927 [Abstract] [Full Text] [Related] Page: [Next] [New Search]